Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of Folate Receptor-positive Circulating Tumor Cells as a Biomarker for Diagnosis

NCT05633680 is registered in ClinicalTrials.gov with Handan First Hospital as lead sponsor.

NCT NCT05633680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05633680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of Folate Receptor-positive Circulating Tumor Cells as a Biomarker for Diagnosis
Lead sponsor
Handan First Hospital
Phase
Observational
Overall status
Unknown status
Start date
February 20, 2020
Completion date
June 20, 2023
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasm, neoplastic cells, circulating